Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc.（LIXT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · LIXT · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Lixte Biotechnology Holdings, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
LIXT 季度内部人买卖趋势
LIXT 内幕交易卖出 · LIXT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · LIXT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
LIXT 高管卖出股份 · LIXT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 29, 2026 | Porter Stuart D Director | Award | 25,000 | — | Form 4 |
| Apr 15, 2026 | Pursglove Geordan Garrett CEO and Chairman of the Board · Director | Award | 350,000 | — | Form 4 |
| Apr 15, 2026 | Stazzone Peter CFO | Award | 50,000 | — | Form 4 |
| Apr 15, 2026 | Felix Lourdes Director | Award | 25,000 | — | Form 4 |
| Apr 15, 2026 | Sawyer Jason David Director | Award | 25,000 | — | Form 4 |
| Apr 15, 2026 | Holloway Michael Andrew Director | Award | 25,000 | — | Form 4 |
| Apr 15, 2026 | Primus Guy Warren Director | Award | 25,000 | — | Form 4 |
| Oct 3, 2023 | van der Baan Bastiaan Jeroen President and CEO · Director | Purchase | 10,000 | $28K | Form 4 |
| Oct 3, 2023 | Bernards Rene Director | Purchase | 5,527 | $14K | Form 4 |
| Oct 2, 2023 | Bernards Rene Director | Purchase | 4,473 | $10K | Form 4 |
| Dec 30, 2022 | van der Baan Bastiaan Jeroen Director | Purchase | 10,000 | $49K | Form 4 |
| Dec 15, 2022 | Bernards Rene Director | Purchase | 15,000 | $8K | Form 4 |
| Dec 9, 2022 | FORMAN ERIC Vice President and COO | Purchase | 1,112 | $701 | Form 4 |
| Dec 12, 2022 | Bernards Rene Director | Purchase | 10,000 | $6K | Form 4 |
| Nov 22, 2022 | FORMAN ERIC Vice President and COO | Purchase | 2,484 | $1K | Form 4 |
| Nov 21, 2022 | FORMAN ERIC Vice President and COO | Purchase | 1,457 | $816 | Form 4 |
| Nov 21, 2022 | Brown Regina Director | Purchase | 2,600 | $2K | Form 4 |
| Nov 21, 2022 | Brown Regina Director | Purchase | 2,400 | $1K | Form 4 |
| Nov 18, 2022 | FORMAN ERIC Vice President and COO | Purchase | 6,059 | $3K | Form 4 |
| Nov 18, 2022 | FORMAN ERIC Vice President and COO | Purchase | 2,500 | $1K | Form 4 |
| Nov 18, 2022 | FORMAN ERIC Vice President and COO | Purchase | 7,648 | $4K | Form 4 |
| Nov 17, 2022 | FORMAN ERIC Vice President and COO | Purchase | 4,852 | $3K | Form 4 |
| Nov 14, 2022 | Bernards Rene Director | Purchase | 52,500 | $28K | Form 4 |
| Dec 17, 2021 | FORMAN ERIC Secretary | Other | 1,333,333 | — | Form 4 |
Pursglove Geordan Garrett
CEO and Chairman of the Board · Director
日期
Apr 15
股数
350,000
均价
—
总金额
—
van der Baan Bastiaan Jeroen
President and CEO · Director
日期
Oct 3
股数
10,000
均价
$2.80
总金额
$28K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 LIXT 内幕交易
LIXT 内幕交易
Lixte Biotechnology Holdings, Inc.（LIXT）内幕交易数据来源于公司内部人（包括Porter Stuart D (Director), Pursglove Geordan Garrett (CEO and Chairman of the Board · Director), Stazzone Peter (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。LIXT内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Lixte Biotechnology Holdings, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
LIXT 内幕交易 · 5个问题Lixte Biotechnology Holdings, Inc.（LIXT）的内部人包括高管和董事，如Porter Stuart D (Director), Pursglove Geordan Garrett (CEO and Chairman of the Board · Director), Stazzone Peter (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026